Comparing Optimized Models of Primary And Specialist Services for Palliative Care
COMPASS-PC
2 other identifiers
interventional
78,302
1 country
2
Brief Summary
Palliative care (PC) seeks to reduce suffering and improve quality of life for patients with serious illnesses and their families. National guidelines recommend that clinicians either provide palliative care themselves (generalist PC) or consult experts (specialist PC) as a standard part of serious illness care. This pragmatic clinical trial will be conducted with 48 hospitals at two large U.S. health systems and enroll more than 78,000 seriously ill hospitalized patients. Eligibility is determined by a mortality prediction score where enrolled patients have at least a 70% risk of dying within 1 year. Enrollment assessment occurs as close as possible to 36 hours post admission. The 48 hospitals will be randomized to 3 arms: (1) standardized usual care, (2) trained generalist PC, or (3) specialist PC. Generalist clinicians are trained using the Center to Advance Palliative Care (CAPC) online trainings. This pragmatic, hybrid effectiveness-implementation parallel-cluster RCT will assess the comparative effectiveness of triggering generalist PC and specialist PC on several patient-centered outcome measures, and follows a pilot feasibility study. We will collect Patient-Reported Outcomes (PROs) surveys from a random subset of enrolled patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2026
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 24, 2025
CompletedFirst Posted
Study publicly available on registry
November 4, 2025
CompletedStudy Start
First participant enrolled
February 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2030
March 12, 2026
January 1, 2026
3.7 years
October 24, 2025
March 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hospital free days
Count of days from enrollment spent alive outside of an acute care hospital through 182 days.
Enrollment- 182 days.
Secondary Outcomes (15)
Patient quality of life
1-month, 3-months, and 6-months post-enrollment
Clinician communication
1-month post-enrollment
Pain management
1-month post-enrollment
Goal concordant care
1-month post-enrollment
Social interaction
1-month post-enrollment
- +10 more secondary outcomes
Other Outcomes (1)
End-of-Life Care
3 months post-patient death
Study Arms (3)
Standardized Usual Care
ACTIVE COMPARATORActive control group, where high-risk patients (i.e., with a 1-year mortality risk between 70% and 94%) will receive usual care. A specialist PC consult is ordered by default for the very high-risk patients (i.e., 1-year mortality risk ≥ 95%), unless clinicians cancel the order.
Trained Generalist Palliative Care
EXPERIMENTALGeneralist clinicians trained in PC domains receive an EHR-based alert to document whether or not they have addressed PC domains for high-risk patients ('accountable justification intervention'). A specialist PC consult is ordered by default for the very high risk patients (i.e., 1-year mortality risk ≥ 95%) unless clinicians cancel the order.
Specialist Palliative Care
EXPERIMENTALA specialist PC consult is ordered by default for all patients with a ≥ 70% 1-year mortality risk ('default order intervention'), unless clinicians cancel the order.
Interventions
A specialist PC consult is automatically ordered for patients meeting a certain threshold of 1-year mortality risk (dependent on arm). An EHR-based Our Practice Advisory (OPA) alert on Open Chart informs clinicians when the default order will become active, and how to cancel an order within 24 hours if they elect to do so.
An EHR-based Our Practice Advisory alert asks generalist clinicians to self-report whether they have provided primary PC by clicking which of 4 key PC domains they have addressed or to provide a brief justification as to why not.
High-risk patients (i.e., with a 1-year mortality risk between 70% and 94%) will receive usual care. For very high-risk patients (i.e., with a 1-year mortality risk of ≥ 95%), an EHR-based Our Practice Advisory (OPA) alert on Open Chart informs clinicians when the default order will become active, and how to cancel an order within 24 hours if they elect to do so.
Eligibility Criteria
You may qualify if:
- Age 18 years of age or older; AND Predicted 1-year mortality risk of 70% or greater; AND Admitted to a study hospital.
You may not qualify if:
- Patients who die or have an active or completed discharge order prior to enrollment time OR
- Readmission within 182 days of an eligible encounter OR
- Ineligible service line, with current admission status labeled as: hospice, acute rehabilitation, skilled nursing facility, long-term acute care, psychiatry, obstetrics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Clinical Research Institutecollaborator
- University of Pennsylvanialead
Study Sites (2)
Kaiser Permanente Southern California
Pasadena, California, 91101, United States
Trinity Health
Livonia, Michigan, 48152, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Scott Halpern, MD, PhD
University of Pennsylvania
- PRINCIPAL INVESTIGATOR
Katherine Courtright, MD, MS
University of Pennsylvania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- John M. Eisenberg Professor of Medicine, Epidemiology, and Medical Ethics & Health Policy
Study Record Dates
First Submitted
October 24, 2025
First Posted
November 4, 2025
Study Start
February 16, 2026
Primary Completion (Estimated)
November 1, 2029
Study Completion (Estimated)
July 31, 2030
Last Updated
March 12, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- The IPD and supporting information will be available between 3 and 6 months after the study completion date, and will be available on the Patient Centered Outcomes Data Repository in line with PCORI's policies for data retention.
- Access Criteria
- Applicants will follow the guidelines as set out on the Patient Centered Outcomes Data Repository for accessing this data set.
De-identified data (the Analyzable Data Set, Full Protocol, metadata, data dictionary, full statistical analysis plan (including all amendments and all documentation for additional work processes)), and analytic code from a PCORI-funded research project from this PCORI-funded clinical trial will be made available on the Patient-Centered Outcomes Data Repository.